Karin de Stricker

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Michael Bau Mortensen · 3 shared papers, 2021–2026 · strength 0.57
   • Paper Circulating tumour DNA as a prognostic tool for surgically treated pancreatic ductal adenocarcinoma. DOI 10.1016/j.humpath.2025.106024↗
   • Paper High overall copy number variation burden by genome-wide methylation profiling holds negative prognostic value in surgi… DOI 10.1016/j.humpath.2023.11.002↗
   • Paper Synchronous detection of pancreatic adenocarcinoma and paraganglioma in a Whipple resection specimen. DOI 10.1016/j.prp.2021.153590↗
2. Sönke Detlefsen · 3 shared papers, 2021–2026 · strength 0.57
   • Paper Circulating tumour DNA as a prognostic tool for surgically treated pancreatic ductal adenocarcinoma. DOI 10.1016/j.humpath.2025.106024↗
   • Paper High overall copy number variation burden by genome-wide methylation profiling holds negative prognostic value in surgi… DOI 10.1016/j.humpath.2023.11.002↗
   • Paper Synchronous detection of pancreatic adenocarcinoma and paraganglioma in a Whipple resection specimen. DOI 10.1016/j.prp.2021.153590↗
3. Per Pfeiffer · 2 shared papers, 2023–2026 · strength 0.43
   • Paper Circulating tumour DNA as a prognostic tool for surgically treated pancreatic ductal adenocarcinoma. DOI 10.1016/j.humpath.2025.106024↗
   • Paper High overall copy number variation burden by genome-wide methylation profiling holds negative prognostic value in surgi… DOI 10.1016/j.humpath.2023.11.002↗
4. Trine Aaquist · 2 shared papers, 2021–2026 · strength 0.39
   • Paper Circulating tumour DNA as a prognostic tool for surgically treated pancreatic ductal adenocarcinoma. DOI 10.1016/j.humpath.2025.106024↗
   • Paper Synchronous detection of pancreatic adenocarcinoma and paraganglioma in a Whipple resection specimen. DOI 10.1016/j.prp.2021.153590↗
5. Carlos Fernández Moro · 1 shared paper, 2026 · strength 0.25
   • Paper Circulating tumour DNA as a prognostic tool for surgically treated pancreatic ductal adenocarcinoma. DOI 10.1016/j.humpath.2025.106024↗
6. Frank Viborg Mortensen · 1 shared paper, 2026 · strength 0.25
   • Paper Circulating tumour DNA as a prognostic tool for surgically treated pancreatic ductal adenocarcinoma. DOI 10.1016/j.humpath.2025.106024↗
7. Ernesto Sparrelid · 1 shared paper, 2026 · strength 0.25
   • Paper Circulating tumour DNA as a prognostic tool for surgically treated pancreatic ductal adenocarcinoma. DOI 10.1016/j.humpath.2025.106024↗
8. Claus Wilki Fristrup · 1 shared paper, 2026 · strength 0.25
   • Paper Circulating tumour DNA as a prognostic tool for surgically treated pancreatic ductal adenocarcinoma. DOI 10.1016/j.humpath.2025.106024↗
9. Jorg H. Kleeff · 1 shared paper, 2026 · strength 0.25
   • Paper Circulating tumour DNA as a prognostic tool for surgically treated pancreatic ductal adenocarcinoma. DOI 10.1016/j.humpath.2025.106024↗
10. Lukas Gammelgaard Rasmussen · 1 shared paper, 2023 · strength 0.18
    • Paper High overall copy number variation burden by genome-wide methylation profiling holds negative prognostic value in surgi… DOI 10.1016/j.humpath.2023.11.002↗
11. Siri Vreim Ørbeck · 1 shared paper, 2023 · strength 0.18
    • Paper High overall copy number variation burden by genome-wide methylation profiling holds negative prognostic value in surgi… DOI 10.1016/j.humpath.2023.11.002↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.